Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-18-062948

Options or other derivatives

  • Chief Executive Officer acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Michelon Francois Roger · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-12-13 Grant or award : show line 1 in the form Stock Options +125,000 125,000 D
Loading xslF345X03/doc4.xml…